|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/14 | |
| A61K 31/4184 | |||
| A61K 31/4188 | |||
| C07D 487/04 | |||
| A61P 37/00 |
| (11) | Patento numeris | 3331889 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16748045.8 |
| Europos patento paraiškos padavimo data | 2016-08-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-06-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/045104 |
| Data | 2016-08-02 |
| (87) | Numeris | WO 2017/023902 |
| Data | 2017-02-09 |
| (30) | Numeris | Data | Šalis |
| 201562200415 P | 2015-08-03 | US |
| (72) |
XIAO, Hai-Yun, US
DHAR, Murali T.G., US
JIANG, Bin, US
DUAN, Jingwu, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | CYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA |
| CYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA |